Schizophrenia-2판

Schizophrenia is one of the most complex and puzzling diseases
to affect mankind. It is the most common of the severe mental
illnesses (psychoses) with an estimated prevalence of 0.5 - 1%
in the general population and accounts for a very large portion
of the day to day workload of the average psychiatrist. 50% of
long-term psychiatric patients in mental hospitals are
schizophrenic.
There is a great deal of controversy about the causes, diagnosis
and treatment of schizophrenia with the consequence that a huge
amount of research is carried out in the field by psychiatrists,
psychologists, neuroscientists and pharmacologists. For the
average practising psychiatrist seeing schizophrenics on a
regular basis, making sense of the vast body of information on
the subject and filtering out what is of clinical relevance can
be very difficult. There is a constant stream of new drugs
emerging and the newer generation of drugs (the so-called
atypicals) is very effective, but often expensive.

The Editors (one American and one British) are both highly
respected clinical psychiatrists who are probably the leading
experts on schizophrenia from their respective countries and
jointly have published almost 150 papers on the subject. They
have brought together a strong group of contributors from the
USA, UK and Europe to produce what will be an essential
reference for the trainee and practising psychiatrist.

The book consists of four sections; descriptive aspects,
causative aspects, physical treatments and
psychological/behavioural/social treatments. There will be
discussion of the theoretical controversies over symptomatology,
classification and aetiology, the relationship of schizophrenia
to the other psychoses, the significance of positive and
negative symptoms and pre-morbid personality. There will be
chapters on organic models of schiziophrenia,
neurodevelopmental, genetic and structural studies and the role
of high-expressed emotion. The final section will cover social
and environmental treatment, the role of the families of
schizophrenics and the psychoanalytical therapies. There is a
new chapter on the patient's perspective written by a former
patient.





Forward, T Crow
Part 1: Descriptive aspects
Chapter 1: Concepts of Schizophrenia
Chapter 2: Descriptive Psychopathology
Chapter 3: Syndromes of Schizophrenia
Chapter 4: Schizophrenia in childhood
Chapter 5: Atypical Psychotic Disorders
Chapter 6: Late Life Schizophrenia
Chapter 7: The Schizophrenia Spectrum Personality Disorders
Chapter 8: Course and Outcome of Schizophrenia
Chapter 9: Depression in Schizophrenia
Chapter 10: Neurocognitive Deficits in Schizophrenia

Part 2: Biological Aspects
Chapter 11: The secondary schizophrenias
Chapter 12: The Epidemiological Horizon
Chapter 13: Factors increasing the risk for schizophrenia
Chapter 14: Genetics of Schizophrenia
Chapter 15: Biology of genetic susceptibility
Chapter 16: Electrophysiology
Chapter 17: Neuropathology of Schizophrenia
Chapter 18: Schizophrenia as a neurodevelopmental disorder
Chapter 19: The Neurochemistry of schizophrenia
Chapter 20: The Dopamine Theory Revisited
Chapter 21: Animal Neuropharmacology and its predicition of
clinical response
Chapter 22: Brain Imaging

Part 3: Physical Treatments
Chapter 23: The Clinical Treatment of Schizophrenia with
Antipsychotic Medication
Chapter 24: The acute treatment of Schizophrenia with
antipscyhotic medication
Chapter 25: Maintenance, medication and relapse prevention
Chapter 26: Treatment resistent Schizophrenia
Chapter 27: Electroconvulsive Therapy in Schizophrenia
Chapter 28: Neuroleptic-induced Acute Extrapyramidal Syndromes
and Tardive Dyskinesia
Chapter29: Non-neurological side effects of antipsychotic agents

Part 4: Social, environmental and psychosocial aspects
Chapter 30: Violence and Schizophrenia
Chapter 31: Schizophrenia and Psyc